Session Title: "Anne Klibanski Visiting Scholar Lecture 9: Innovations in the Detection, Diagnosis, and Treatment of Breast Cancer"

The Anne Klibanski Visiting Lecture Series was created to support and advance the careers of women. These lectures bring together faculty from institutions that have hosted Anne Klibanski Scholars with MGH scholars, on topics that overlap both research areas.

Dr. Bahl will present on “Tomosynthesis, Contrast-Enhanced Mammography, and Artificial Intelligence to Improve the Detection and Diagnosis of Breast Cancer.”
Dr. Bryce will present on “Cryoablation of Breast Cancer.”

Learning Objectives:
Upon completion of this activity, participants will be able to:  

• Recognize the advantages of digital breast tomosynthesis and contrast-enhanced mammography over conventional digital 2D mammography.
• Review interpretive and noninterpretive artificial intelligence applications for breast imaging.
• Discuss justifications and approach for cryoablation of breast cancer.
• Describe a potential role of cryoablation in boosting immune response.

This activity is intended for: Faculty and faculty trainees.

Presenters:  
Manisha Bahl, MD, Director of Breast Imaging Fellowship Program, MGH/HMS  
Yolanda Bryce, MD, Director of Interventional Radiology Training Program, Memorial Sloan Kettering Cancer Center.

Course Director: Miriam A. Bredella, MD

For questions regarding the registration process, please contact Partners Office of Continuing Professional Development at partnerscpd@partners.org.

You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.

ACCREDITATION

Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.